469 related articles for article (PubMed ID: 29622080)
21. Biomarkers for Immunotherapy.
Bustamante-Alvarez JG; Owen DH
Thorac Surg Clin; 2020 May; 30(2):207-214. PubMed ID: 32327179
[TBL] [Abstract][Full Text] [Related]
22. The Role of Targeted Agents and Immunotherapy in Older Patients with Non-small Cell Lung Cancer.
Gomes F; Tay R; Chiramel J; Califano R
Drugs Aging; 2018 Sep; 35(9):819-834. PubMed ID: 30105645
[TBL] [Abstract][Full Text] [Related]
23. Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?
Gardiner RE; Jahangeer S; Forde P; Ariffin AB; Bird B; Soden D; Hinchion J
Cancer Metastasis Rev; 2015 Mar; 34(1):129-44. PubMed ID: 25726003
[TBL] [Abstract][Full Text] [Related]
24.
Luan X; Huang Y; Gao S; Sun X; Wang S; Ma L; Teng X; Lu H; Yu J; Yuan S
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2336-2342. PubMed ID: 27631310
[TBL] [Abstract][Full Text] [Related]
25. Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer.
Weller A; O'Brien MER; Ahmed M; Popat S; Bhosle J; McDonald F; Yap TA; Du Y; Vlahos I; deSouza NM
Eur J Cancer; 2016 May; 59():65-78. PubMed ID: 27016624
[TBL] [Abstract][Full Text] [Related]
26. Dilemmas in Lung Cancer Staging.
Vlahos I
Radiol Clin North Am; 2018 May; 56(3):419-435. PubMed ID: 29622077
[TBL] [Abstract][Full Text] [Related]
27. (99m)Tc-3PRGD 2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab.
Ma Q; Min K; Wang T; Chen B; Wen Q; Wang F; Ji T; Gao S
Ann Nucl Med; 2015 Jul; 29(6):519-27. PubMed ID: 25911312
[TBL] [Abstract][Full Text] [Related]
28. Role of 18F-FDG PET in assessment of response in non-small cell lung cancer.
Hicks RJ
J Nucl Med; 2009 May; 50 Suppl 1():31S-42S. PubMed ID: 19380411
[TBL] [Abstract][Full Text] [Related]
29. Does computed tomography or positron emission tomography response after neoadjuvant chemotherapy for resectable non-small-cell lung cancer predict survival?
Patz EF
J Clin Oncol; 2008 Oct; 26(28):4542-3. PubMed ID: 18824705
[No Abstract] [Full Text] [Related]
30. Immunotherapy and lung cancer: current developments and novel targeted therapies.
Domingues D; Turner A; Silva MD; Marques DS; Mellidez JC; Wannesson L; Mountzios G; de Mello RA
Immunotherapy; 2014; 6(11):1221-35. PubMed ID: 25496336
[TBL] [Abstract][Full Text] [Related]
31. A banner year for immunotherapy and targeted therapy.
Carlisle JW; Ramalingam SS
Nat Rev Clin Oncol; 2019 Feb; 16(2):79-80. PubMed ID: 30538305
[No Abstract] [Full Text] [Related]
32. Current Landscape of Personalized Therapy.
Horn L; Cass AS
Thorac Surg Clin; 2020 May; 30(2):121-125. PubMed ID: 32327170
[TBL] [Abstract][Full Text] [Related]
33. [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].
Bílek O; Bohovicová L; Demlová R; Poprach A; Lakomý R; Zdražilová-Dubská L
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):78-87. PubMed ID: 27846725
[TBL] [Abstract][Full Text] [Related]
34. Evolving Treatment Options for Lung Cancer.
Morgensztern D; Herbst RS
Hematol Oncol Clin North Am; 2017 Feb; 31(1):xiii-xiv. PubMed ID: 27912837
[No Abstract] [Full Text] [Related]
35. Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival.
Everitt S; Ball D; Hicks RJ; Callahan J; Plumridge N; Trinh J; Herschtal A; Kron T; Mac Manus M
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):947-955. PubMed ID: 29063854
[TBL] [Abstract][Full Text] [Related]
36. Cone-beam computed tomography for lung cancer - validation with CT and monitoring tumour response during chemo-radiation therapy.
Michienzi A; Kron T; Callahan J; Plumridge N; Ball D; Everitt S
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):263-270. PubMed ID: 27804280
[TBL] [Abstract][Full Text] [Related]
37. Current clinical immunotherapy targets in advanced nonsmall cell lung cancer (NSCLC).
McCarthy F; Roshani R; Steele J; Hagemann T
J Leukoc Biol; 2013 Dec; 94(6):1201-6. PubMed ID: 23695306
[TBL] [Abstract][Full Text] [Related]
38. Chemoradiotherapy of locally advanced nonsmall cell lung cancer: state of the art and perspectives.
Antoni D; Mornex F
Curr Opin Oncol; 2016 Mar; 28(2):104-9. PubMed ID: 26848885
[TBL] [Abstract][Full Text] [Related]
39. [Immunotherapy and multidisciplinary approach to treatment in lung cancer].
Karadurmuş N; Kaya A; Göksel T; Yılmaz Ü; Tülek N
Tuberk Toraks; 2020 Mar; 68(1):66-75. PubMed ID: 32718141
[TBL] [Abstract][Full Text] [Related]
40. [Progress in immunotherapy for non-small cell lung cancer].
Xu Y; Wang M
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):34-41. PubMed ID: 24398312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
